Skip to main content
Caplight Logo









ZeClinics

ZeClinics

Private
Sant Feliu de LlobregatHealthcare & Life Scienceshttps://www.zeclinics.com/

Last Round

Grant

Dec 20, 2022

Est. Valuation

$1.21M

Total Funding Raised

$3.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ZeClinics is a contract research organization (CRO) that provides preclinical services to accelerate research and development for the pharmaceutical, agrochemical, food, and cosmetic industries using zebrafish.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

contract research organizationCROzebrafish modelpreclinical CROpreclinical researchtoxicology screeningefficacy studiesdrug discoveryalternative to animal testinghigh-throughput screeningCRISPR gene editinggenetic model generationin vivo modeltarget validationcosmetic testingagrochemical testingAI phenotyping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZeClinics Comparables

Compare ZeClinics with similar companies based on industry and business-model similarity.

ZeClinics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zefit
87%
Hunter Biotechnology
85%
InVivo Biosystems
85%

ZeClinics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 20, 2022
GrantOct 19, 2022
GrantDec 7, 2016
CrowdfundingMay 31, 2015

Key People

Founding team and executive leadership

Simone Calzolari

Chief Executive Officer

Executive Team

ZeClinics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 6, representing 29% of headcount.

  • Dec 20, 2022

    $726K grant received from Spanish Government and NextGenerationEU.

ZeClinics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ZeClinics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ZeClinics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSant Feliu de Llobregat
Employee Range21
Year Founded2013
Last FundingDec 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?